Skip to main content
. 2017 Jul 17;38(3):1420–1430. doi: 10.3892/or.2017.5826

Figure 7.

Figure 7.

Bufalin synergistically inhibits the proliferation of colorectal cancer cells with cisplatin and decreases stemness in vivo. A subcutaneous xenograft model of HCT116 cells was treated with cisplatin alone or cisplatin + bufalin for 3 weeks. Tumors were photographed (A) and weighed (B). (C) Hematoxylin and eosin staining and immunohistochemistry were performed to evaluate the expression of stemness markers.